Aspects of Peptidomimetics - Peptide and Protein Design for Biopharmaceutical Applications - page 108

[60] C. H. Stammer, Cyclopropane amino-acids (2,3-methanoamino and 3,4-methanoa-
mino acids), Tetrahedron ,46, 2231-2254 (1990).
[61] M. Horikawa, Y. Shigeri, N. Yumoto, S. Yoshikawa, T. Nakajima and Y. Ohfune,
Syntheses of potent Leu-enkephalin analogues possessing b-hydroxy-a,a-disubsti-
tuted-a-amino acid and their characterization to opioid receptors,

Bioorg.Med.Chem.Lett ., 8, 2027-2032 (1998).
[62] E. Gershonov, R. Granoth, E. Tzehoval, Y. Gaoni and M. Fridkin, 1-aminocyclobu-
tanecarboxylic acid derivatives as novel structural elements in bioactive peptides:
application to tuftsin analogues, J.Med.Chem ., 39, 4833-4843 (1996).
[63] O. O. Grygorenko, O. S. Artamonov, G. V. Palamarchuk, R. I. Zubatyuk, O. V. Shishkin
and I. V. Komarov, Stereoselective synthesis of 2,4-methanoproline homologues,
Tetrahedron - Asymmetry , 17, 252-258 (2006).
[64] F. Couty, G. Evano and N. Rabasso, Synthesis of enantiopure azetidine 2-carboxylic
acids and their incorporation into peptides, Tetrahedron - Asymmetry , 14, 2407-
2412 (2003).
[65] Z. Sajjadi and W. D. Lubell, Amino acid-azetidine chimeras: synthesis of enantio-
pure 3-substituted azetidine-2-carboxylic acids, J.Peptide Res ., 65, 298-310 (2005).
[66] I. B. Parr, S. K. Boehlein, A. B. Dribben, S. M. Schuster and N. G. J. Richards,
Mapping the A spartic A cid B inding S ite of Escherichia coli A sparagine S ynthetase B
U sing S ubstrate A nalogues, J.Med.Chem ., 39, 2367-2378 (1996).
[67] A. Mamai, N. E. Hughes, A. Wurthmann and J. S. Madalengoitia, Synthesis
of conformationally constrained arginine and ornithine analogues based on the
3-substituted pyrrolidine framework, J.Org.Chem ., 66, 6483-6486 (2001).
[68] N. Pellegrini, M. Schmitt, S. Guery and J. J. Bourguignon, New strategies towards
proline derivatives as conformationally constrained arginine analogues, Tetrahedron
Lett ., 43, 3243-3246 (2002).
[69] J. Quancard, A. Labonne, Y. Jacquot, G. Chassaing, S. Lavielle and P. Karoyan,
Asymmetric synthesis of 3-substituted proline chimeras bearing polar side chains of
proteinogenic amino acids, J.Org.Chem ., 69, 7940-7948 (2004).
[70] J. Quancard, H. Magellan, S. Lavielle, G. Chassaing and P. Karoyan, Amino-zinc-
ene-enolate cyclisation: a short access to (2 S ,3 R )- and (2 S ,3 S )-3-benzylprolines
(3-benzylpyrrolidine-2-carboxylic acids), Tetrahedron Lett ., 45, 2185-2187 (2004).
[71] G. A. Flynn, A. L. Akeson, R. Dharanipragada, M. J. Genin, J. A. Malikayil,
R. Pottorf, J. S. Sabol, H. Schreuder, R. Tomlinson, P. Waid, R. Barrett, J. Jacobs
and S. Yanofsky, Application of conformationally restricted peptidomimetics to
modeling the bound conformation of peptide antagonists with the IL-1 receptor,
Lett.Pept.Sci ., 5, 93-100 (1998).
[72] H. I. Mosberg and H. B. Kroona, Incorporation of a novel conformationally
restricted tyrosine analogue into a cyclic, d opioid receptor selective tetrapeptide
(JOM-13) enhances d receptor binding affinity and selectivity, J.Med.Chem ., 35,
4498-4500 (1992).
[73] M. Cai, C. Cai, A. V. Mayorov, C. Xiong, C. M. Cabello, V. A. Soloshonok,
J. R. Swift, D. Trivedi and V. J. Hruby, Biological and conformational study of
beta-substituted prolines in MT-II template: steric effects leading to human MC5
receptor selectivity, J.Peptide Res ., 63, 116-131 (2004).
[74] S. Sagan, J. Quancard, O. Lequin, P. Karoyan, G. Chassaing and S. Lavielle,
Conformational analysis of the C-terminal Gly-Leu-Met-NH 2 tripeptide of substance
P bound to the NK-1 receptor, Chem.Biol ., 12, 555-565 (2005).